Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference33 articles.
1. Effects of chemotherapy and hormonal therapy for early cancer on recurrence and 15-year survival: an overview of the randomized trials;Lancet,2005
2. Effect of anastrazole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;Forbes;Lancet Oncol,2008
3. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;Thürlimann;N Engl J Med,2005
4. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (intergroup exemestane study): a randomized controlled trial;Coombes;Lancet,2007
5. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA;Goss;J Natl Cancer Inst,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance;Cellular Signalling;2020-06
2. Fulvestrant: Do not forget the history and opportunities for cost saving from real-world data;Cancer Research, Statistics, and Treatment;2020
3. Shades of chemical beauty: An overview of synthetic routes to some anticancer drugs;Synthetic Communications;2017-06-07
4. Triggering of Suicidal Erythrocyte Death by Exemestane;Cellular Physiology and Biochemistry;2017
5. Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer;Clinical Medicine Insights: Oncology;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3